Literature DB >> 14532245

Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates.

Manzour Hernando Hazbón1, Nora Guarín, Beatriz Eugenia Ferro, Ana Lucía Rodríguez, Luz Angela Labrada, Rafael Tovar, Paul F Riska, William R Jacobs.   

Abstract

Luciferase reporter phages (LRPs) have proven to be efficient tools for drug susceptibility testing of Mycobacterium tuberculosis. Luminometric detection of LRP activity offers higher sensitivity and quantitative results, while a Polaroid film detection method offers a "low-tech" inexpensive alternative that is called the Bronx box. In this work we evaluated, improved, and compared the performance of the luminometer and the Bronx box formats for drug susceptibility testing with LRPs by using 51 clinical isolates of M. tuberculosis, with the agar proportion method (PM) serving as reference. The sensitivity in detecting resistance to isoniazid and rifampin, antibiotics that define multidrug resistance (MDR), was 100% for both methods. The turnaround time for results was reduced from 3 weeks for PM to 54 or 94 h for luminometry or the Bronx box, respectively. These results support the utility of LRPs as a screening test for the surveillance of MDR tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532245      PMCID: PMC254324          DOI: 10.1128/JCM.41.10.4865-4869.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

Authors:  M A Espinal; A Laszlo; L Simonsen; F Boulahbal; S J Kim; A Reniero; S Hoffner; H L Rieder; N Binkin; C Dye; R Williams; M C Raviglione
Journal:  N Engl J Med       Date:  2001-04-26       Impact factor: 91.245

2.  The use of luciferase-reporter phage for antibiotic-susceptibility testing of mycobacteria.

Authors:  P F Riska; W R Jacobs
Journal:  Methods Mol Biol       Date:  1998

3.  Evaluation of Etest for susceptibility testing of multidrug-resistant isolates of Mycobacterium tuberculosis.

Authors:  M H Hazbón; M del Socorro Orozco; L A Labrada; R Tovar; K A Weigle; A Wanger
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico.

Authors:  N Banaiee; M Bobadilla-Del-Valle; S Bardarov; P F Riska; P M Small; A Ponce-De-Leon; W R Jacobs; G F Hatfull; J Sifuentes-Osornio
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest.

Authors:  A Wanger; K Mills
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

6.  Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box.

Authors:  P F Riska; Y Su; S Bardarov; L Freundlich; G Sarkis; G Hatfull; C Carrière; V Kumar; J Chan; W R Jacobs
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

7.  Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis.

Authors:  L B Heifets; M D Iseman; P J Lindholm-Levy
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

8.  Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages.

Authors:  W R Jacobs; R G Barletta; R Udani; J Chan; G Kalkut; G Sosne; T Kieser; G J Sarkis; G F Hatfull; B R Bloom
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

9.  Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: comparison with the Mycobacteria Growth Indicator Tube (MGIT) system.

Authors:  Svetoslav Bardarov; Horng Dou; Katherine Eisenach; Niaz Banaiee; S u Ya; John Chan; William R Jacobs; Paul F Riska
Journal:  Diagn Microbiol Infect Dis       Date:  2003-01       Impact factor: 2.803

10.  Improved outcomes for patients with multidrug-resistant tuberculosis.

Authors:  G S Turett; E E Telzak; L V Torian; S Blum; D Alland; I Weisfuse; B A Fazal
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

View more
  10 in total

1.  Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance.

Authors:  Manzour Hernando Hazbón; Miriam Bobadilla del Valle; Marta Inírida Guerrero; Mandira Varma-Basil; Ingrid Filliol; Magali Cavatore; Roberto Colangeli; Hassan Safi; Helen Billman-Jacobe; Caroline Lavender; Janet Fyfe; Lourdes García-García; Amy Davidow; Michael Brimacombe; Clara Inés León; Tania Porras; Mridula Bose; Fernando Chaves; Kathleen D Eisenach; José Sifuentes-Osornio; Alfredo Ponce de León; M Donald Cave; David Alland
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

Review 2.  Reporter phage and breath tests: emerging phenotypic assays for diagnosing active tuberculosis, antibiotic resistance, and treatment efficacy.

Authors:  Paras Jain; David S Thaler; Mamoudou Maiga; Graham S Timmins; William R Bishai; Graham F Hatfull; Michelle H Larsen; William R Jacobs
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

3.  Molecular Genetics of Mycobacteriophages.

Authors:  Graham F Hatfull
Journal:  Microbiol Spectr       Date:  2014-03-07

4.  Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South Africa.

Authors:  Niaz Banaiee; Vanessa January; Charmaine Barthus; Maureen Lambrick; Denise Roditi; Marcel A Behr; William R Jacobs; Lafras M Steyn
Journal:  Tuberculosis (Edinb)       Date:  2007-11-05       Impact factor: 3.131

5.  Phage Therapy - Everything Old is New Again.

Authors:  Andrew M Kropinski
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

6.  Port Site Tuberculosis Presenting as Nonhealing Sinus After Laparoscopic Appendicectomy.

Authors:  Sanjay Marwah; Kapil Dev Shivaran; Jyotsna Sen; Nisha Marwah
Journal:  Indian J Surg       Date:  2013-03-13       Impact factor: 0.656

7.  Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons.

Authors:  S-Y Grace Lin; William Probert; Melanie Lo; Edward Desmond
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

8.  Phage-based platforms for the clinical detection of human bacterial pathogens.

Authors:  David A Schofield; Natasha J Sharp; Caroline Westwater
Journal:  Bacteriophage       Date:  2012-04-01

Review 9.  Rapid clinical bacteriology and its future impact.

Authors:  Alex van Belkum; Géraldine Durand; Michel Peyret; Sonia Chatellier; Gilles Zambardi; Jacques Schrenzel; Dee Shortridge; Anette Engelhardt; William Michael Dunne
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

10.  Fluoromycobacteriophages for rapid, specific, and sensitive antibiotic susceptibility testing of Mycobacterium tuberculosis.

Authors:  Mariana Piuri; William R Jacobs; Graham F Hatfull
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.